Long-term, clinical follow-up in fatty liver patients

Digestive Diseases

Volumn 28, Issue 6, 2010, Pages 709-714

  Bendtsen, Flemming ^a,b   Dam Larsen, Sanne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Alcohol; Liver; Prognosis; Steatosis

Indexed keywords

ALCOHOLIC FATTY LIVER; ARTICLE; COHORT ANALYSIS; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

ALCOHOLISM; BIOPSY; CAUSE OF DEATH; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; MALE; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 79955582343     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324277     Document Type: Article

References (12)

1. Lefkowitch JH: Morphology of alcoholic liver disease. Clin Liver Dis 2005; 9: 37-53. (Pubitemid 40341945)
2. French SW, Nash J, Shitabata P, Kachi K, Hara C, Chedid A, Mendenhall CL: Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis 1993; 13: 154-169. (Pubitemid 23183171)
3. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH: The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007; 27: 173-193. (Pubitemid 46871663)
4. Sørensen TI, Orholm M, Bentsen KD, Høybye G, Eghøje K, Christoffersen P: Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241-244.
5. Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, Baron JA, Sørensen HT: Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. Hepatogastroenterology 2003; 50: 2101-2104. (Pubitemid 37468003)
6. Orholm M, Sørensen TI, Bentsen K, Høybye G, Eghøje K, Christoffersen P: Mortality of alcohol abusing men prospectively assessed in relation to history of abuse and degree of liver injury. Liver 1985; 5: 253-260. (Pubitemid 16203411)
7. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL: Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974.
8. Ong JP, Younossi ZM: Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007; 11: 1-16, vii. (Pubitemid 46829973)
9. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873. (Pubitemid 46489550)
10. Dam-Larsen S, Becker U, Franzmann MB, Larsen K, Christoffersen P, Bendtsen F: Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol 2009; 44: 1236-1243.
11. Dam-Larsen S, Franzmann MB, Christoffersen P, Larsen K, Becker U, Bendtsen F: Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol 2005; 40: 460-467. (Pubitemid 40546915)
12. Teli MR, Day CP, Burt AD, Bennett MK, James OF: Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346: 987-990.